Safety and efficacy profile of bioresorbable‐polylactide‐polymer‐biolimus‐A9‐eluting stents versus durable‐polymer‐everolimus‐ and zotarolimus‐eluting stents in patients with acute coronary syndrome
1. Cardiology, Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland;2. Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany